Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients?
1 Department of Neuro-ophthalmology (SHW, GTP), Moorfields Eye Hospital, London, United Kingdom; Medical Eye Unit (SHW, GTP), St. Thomas' Hospital, London, United Kingdom; Department of Neuro-ophthalmology (SHW, GTP), National Hospital for Neurology and Neurosurgery, London, United Kingdom; and Departments of Neurology and Ophthalmology (WC), University of Michigan, Ann Arbor, Michigan.